Bulletin
Investor Alert

New York Markets After Hours

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 15, 2021, 4:47 p.m.

/zigman2/quotes/203509482/composite

$

405.88

Change

-4.05 -0.99%

Volume

Volume 32,769

Quotes are delayed by 20 min

/zigman2/quotes/203509482/composite

Today's close

$ 408.10

$ 409.93

Change

+1.83 +0.45%

Day low

Day high

$408.15

$411.90

Open

52 week low

52 week high

$288.01

$555.77

Open

Insider Actions for Illumina Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/05/2021 Joydeep Goswami
SVP Corp Business Development
115   Derivative/Non-derivative trans. at $387.98 per share. 44,617
09/28/2021 Susan H. Tousi
SVP, Chief Commercial Officer
100   Disposition at $418.04 per share. 41,804
09/22/2021 Charles E. Dadswell
SVP & General Counsel
314   Disposition at $436.69 per share. 137,120
08/30/2021 Susan H. Tousi
SVP, Chief Commercial Officer
300   Disposition at $463.5 per share. 139,050
08/23/2021 Charles E. Dadswell
SVP & General Counsel
314   Disposition at $489.1 per share. 153,577
08/18/2021 Alex Aravanis
SVP, Chief Technology Officer
9,949   Derivative/Non-derivative trans. at $510.61 per share. 5,080,058
08/18/2021 Alex Aravanis
SVP, Chief Technology Officer
21,653   Award at $510.61 per share. 11,056,238
08/04/2021 Susan H. Tousi
SVP, Chief Commercial Officer
1,000   Disposition at $500 per share. 500,000
07/28/2021 Susan H. Tousi
SVP, Chief Commercial Officer
300   Disposition at $486.41 per share. 145,923
07/22/2021 Charles E. Dadswell
SVP & General Counsel
314   Disposition at $482.23 per share. 151,420
06/28/2021 Susan H. Tousi
SVP, Chief Commercial Officer
300   Disposition at $478.95 per share. 143,685

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
9 Sales
21,653
12,706
Last 6 months
10 Purchases
26 Sales
29,494
30,288
Last 12 months
37 Purchases
137 Sales
109,632
145,352

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Robert P. Ragusa
Chief Operations Officer
Mr. Sam A. Samad
Chief Financial Officer & Senior Vice President
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Mr. Steve Phillpott
Chief Information Officer & Senior Vice President
Dr. Phillip G. Febbo
Chief Medical Officer
Dr. Joydeep Goswami
SVP-Corporate Development & Strategic Planning
Mr. Min-Jui Shen
Director-Scientific Operations & Research
Ms. Susan H. Tousi
Chief Commercial Officer
Mr. Charles E. Dadswell
Secretary, Senior VP & Compliance Officer
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathy Reeves
Chief Marketing Officer
Mr. Jose A. Torres
Chief Accounting Officer & Vice President
Ms. Juliet C. Cunningham
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.